Improving Estimates of Alcohol-Attributable Deaths in the United States: Impact of Adjusting for the Underreporting of Alcohol Consumption.


Journal

Journal of studies on alcohol and drugs
ISSN: 1938-4114
Titre abrégé: J Stud Alcohol Drugs
Pays: United States
ID NLM: 101295847

Informations de publication

Date de publication:
01 2022
Historique:
entrez: 18 1 2022
pubmed: 19 1 2022
medline: 1 2 2022
Statut: ppublish

Résumé

Self-reported alcohol consumption in U.S. public health surveys covers only 30%-60% of per capita alcohol sales, based on tax and shipment data. To estimate alcohol-attributable harms using alcohol-attributable fractions, accurate measures of total population consumption and the distribution of this drinking are needed. This study compared methodological approaches of adjusting self-reported survey data on alcohol consumption to better reflect sales and assessed the impact of these adjustments on the distribution of average daily consumption (ADC) levels and the number of alcohol-attributable deaths. Prevalence estimates of ADC levels (i.e., low, medium, and high) among U.S. adults who responded to the 2011-2015 Behavioral Risk Factor Surveillance System (BRFSS; Self-reported ADC in the BRFSS accounted for 31.3% coverage of per capita alcohol sales without adjustments, 36.1% using indexed-BRFSS data, and 44.3% with National Alcohol Survey adjustments. Per capita sales adjustments decreased low ADC prevalence estimates and increased medium and high ADC prevalence estimates. Estimated alcohol-attributable deaths ranged from approximately 91,200 per year (BRFSS unadjusted; Method 1) to 125,200 per year (100% of per capita sales adjustment; Method 6). Adjusting ADC to reflect total U.S. alcohol consumption (e.g., adjusting to 73% of per capita sales) has implications for assessing the impact of excessive drinking on health outcomes, including alcohol-attributable death estimates.

Identifiants

pubmed: 35040769
pmc: PMC8819896

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-144

Subventions

Organisme : NIAAA NIH HHS
ID : K01 AA024832
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA005595
Pays : United States
Organisme : OSTLTS CDC HHS
ID : U38 OT000225
Pays : United States

Déclaration de conflit d'intérêts

None of the authors have any conflicts of interest or financial disclosures.

Références

Addiction. 2018 Dec;113(12):2245-2249
pubmed: 30014539
Alcohol Clin Exp Res. 2007 Oct;31(10):1714-22
pubmed: 17651465
J Subst Use. 2017;22(4):434-441
pubmed: 28757806
Alcohol Clin Exp Res. 2019 Mar;43(3):509-521
pubmed: 30742317
Scand J Public Health. 2019 Jun;47(4):469-473
pubmed: 30973075
Lancet Public Health. 2020 Jan;5(1):e51-e61
pubmed: 31910980
Addiction. 2010 Jun;105(6):1018-29
pubmed: 20331552
Addiction. 2006 Dec;101(12):1711-8
pubmed: 17156170
Addiction. 2017 Nov;112(11):2053-2063
pubmed: 28556274
Am J Prev Med. 2010 Feb;38(2):217-29
pubmed: 20117579
J Subst Abuse. 2000;12(1-2):33-49
pubmed: 11288473
Am J Public Health. 2013 Apr;103(4):641-8
pubmed: 23409916
Popul Health Metr. 2010 Mar 04;8:3
pubmed: 20202213
BMC Public Health. 2014 Dec 18;14:1297
pubmed: 25519144
Addiction. 2015 Sep;110(9):1505-12
pubmed: 25845815
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
BMC Public Health. 2010 May 18;10:258
pubmed: 20482788
Inj Prev. 2016 Apr;22 Suppl 1:i6-11
pubmed: 26718549
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Alcohol Alcohol. 2011 Nov-Dec;46(6):709-13
pubmed: 21949190
JAMA. 2018 Apr 10;319(14):1444-1472
pubmed: 29634829
J Clin Epidemiol. 2016 Aug;76:209-17
pubmed: 26968936
Drug Alcohol Rev. 2020 Sep;39(6):624-631
pubmed: 32250491
Alcohol Alcohol. 2018 Sep 1;53(5):586-596
pubmed: 29590313
Am J Prev Med. 2020 Nov;59(5):669-677
pubmed: 32747177
Int J Epidemiol. 1999 Apr;28(2):219-24
pubmed: 10342682
Addiction. 2004 Aug;99(8):1024-33
pubmed: 15265099
Int J Drug Policy. 2011 Mar;22(2):153-60
pubmed: 21242085
Addiction. 2010 Sep;105(9):1589-96
pubmed: 20626370
J Stud Alcohol Drugs. 2017 May;78(3):375-386
pubmed: 28499102
Ann Emerg Med. 1999 Jun;33(6):659-68
pubmed: 10339681
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1428-1433
pubmed: 33001874
Am J Prev Med. 2009 Dec;37(6):556-69
pubmed: 19944925
Br J Cancer. 2015 Feb 3;112(3):580-93
pubmed: 25422909

Auteurs

Marissa B Esser (MB)

Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Adam Sherk (A)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Meenakshi Sabina Subbaraman (MS)

Alcohol Research Group, Public Health Institute, Emeryville, California.

Priscilla Martinez (P)

Alcohol Research Group, Public Health Institute, Emeryville, California.

Katherine J Karriker-Jaffe (KJ)

Alcohol Research Group, Public Health Institute, Emeryville, California.
RTI International--Berkeley Office, Berkeley, California.

Jeffrey J Sacks (JJ)

Sue Binder Consulting, Inc., Decatur, Georgia.

Timothy S Naimi (TS)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH